Quest Pharmatech Inc logo

QPT - Quest Pharmatech Inc News Story

C$0.16 0.0  0.0%

Last Trade - 10/08/20

Sector
Healthcare
Size
Micro Cap
Market Cap £15.4m
Enterprise Value £15.3m
Revenue £n/a
Position in Universe 1182nd / 2675

BRIEF-Oncoquest Announces Publication Of Two Reports Related To Oregovomab Phase 2 Clinical Trial

Tue 24th March, 2020 12:10pm
March 24 (Reuters) - Quest Pharmatech Inc  QPT.V :
    * ONCOQUEST ANNOUNCES PUBLICATION OF TWO REPORTS RELATED TO
OREGOVOMAB PHASE 2 CLINICAL TRIAL, THE COMPANY'S LEAD
INVESTIGATIONAL DRUG IN FRONTLINE OVARIAN CANCER
    * QUEST PHARMATECH INC - CURRENTLY PLANNING TO LAUNCH A
PHASE 3
TRIAL IN Q2 2020.

Source text for Eikon:  ID:nCNWZtqjfa 
Further company coverage:  QPT.V 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.